Everforth (EFOR) Lands A $30 Million DHA Contract, Is The Rebound Already Fully Priced?

Simply Wall St.

18 hours ago

Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics. See our ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2662675750"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662675750\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662675750?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9612011-choice2-main-header/1585186745736","is_english":true,"pubTime":"2026-08-26 05:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662675750","market":"us","top_or_hot":-1,"title":"Everforth (EFOR) Lands A $30 Million DHA Contract, Is The Rebound Already Fully Priced?","media":"Simply Wall St.","content":"<div>\n<p>Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics. See our ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nyse-efor/everforth/news/everforth-efor-lands-a-30-million-dha-contract-is-the-reboun\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Everforth (EFOR) Lands A $30 Million DHA Contract, Is The Rebound Already Fully Priced?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEverforth (EFOR) Lands A $30 Million DHA Contract, Is The Rebound Already Fully Priced?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-26 05:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/software/nyse-efor/everforth/news/everforth-efor-lands-a-30-million-dha-contract-is-the-reboun><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics. See our ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nyse-efor/everforth/news/everforth-efor-lands-a-30-million-dha-contract-is-the-reboun\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4134","symbol_name":"信息科技咨询与其它服务","start_time":0,"source_url":"https://simplywall.st/stocks/us/software/nyse-efor/everforth/news/everforth-efor-lands-a-30-million-dha-contract-is-the-reboun","article_id":"2662675750","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9612011-choice2-main-header/1585186745736"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-efor/everforth/news/everforth-efor-lands-a-30-million-dha-contract-is-the-reboun","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662675750","pubTimestamp":1787692994,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics.\nSee our latest analysis for Everforth.\nThe recent four year Defense Health Agency contract has arrived during a sharp rebound in Everforth’s share price, with a 30 day share price return of 57.77% and a 90 day share price return of 68.74%. However, the 1 year total shareholder return is still down 38.59%...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4134":"信息科技咨询与其它服务","EFOR":"EVERFORTH INC"},"translate_title":"Everforth (EFOR) 获得 3000 万美元的 DHA 合同，反弹是否已经完全定价？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EFOR":1.5},"content_text":"Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics. See our latest analysis for Everforth. The recent four year Defense Health Agency contract has arrived during a sharp rebound in Everforth’s share price, with a 30 day share price return of 57.77% and a 90 day share price return of 68.74%. However, the 1 year total shareholder return is still down 38.59% and the 5 year total shareholder return is down 71.09%. If this contract has put government focused IT and AI on your radar, it could be worth scanning the market for other potential opportunities through the 76 profitable AI stocks that aren't just burning cash Everforth has almost doubled in three months yet still screens at a large discount to some fair value estimates while trading above analyst targets. Is the market re-rating early, or is the earlier caution still justified? AdvertisementMost Popular Narrative: 18.9% Overvalued The most followed valuation narrative for Everforth pegs fair value at $27.33, which is below the recent $32.50 close, and frames today’s price as richer than that estimate. It focuses heavily on how future earnings, margins and share count could evolve under a reset set of expectations.  Ongoing investments in cloud, AI, and cybersecurity solutions, supported by robust demand from both commercial and federal clients, are driving a growing pipeline of high-margin consulting contracts, positioning ASGN to benefit from clients' digital modernization roadmaps, which is likely to accelerate future revenue growth and improve overall net margins.  Read the complete narrative. Read the complete narrative. To understand why this narrative still sees upside from lower expectations, focus on the key pieces: margin assumptions, earnings growth and how aggressively the share count could shrink. Result: Fair Value of $27.33 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, Everforth still faces risks around softer commercial IT demand and pressure on federal margins, which could challenge the margin expansion narrative investors are watching. Find out about the key risks to this Everforth narrative. Another View On Everforth’s Valuation While the most followed Everforth narrative flags the stock as 18.9% above its $27.33 fair value estimate, the market pricing tells a different story. At a P/E of 16x, Everforth trades below both peer averages at 18.4x and the US IT industry at 17.2x, and well below a fair ratio of 35.6x that the regression model suggests the market could move towards over time. Is this discount a cushion against downside or a signal that investors still doubt the earnings story? For a closer look at how the numbers stack up against peers and that higher fair ratio, including what it could mean for valuation risk and opportunity, take a look at the See what the numbers say about this price — find out in our valuation breakdown. NYSE:EFOR P/E Ratio as at Aug 2026Next Steps With Everforth positioned between caution and renewed interest, it can be useful to move quickly, review the underlying data, and form your own view using these 3 key rewards and 3 important warning signs Looking for more investment ideas beyond Everforth? If you are weighing what Everforth’s latest moves mean for your portfolio, this is also a good moment to scan the wider market for fresh opportunities.  Spot potential value opportunities early by checking companies that appear mispriced when compared with their fundamentals through the 49 high quality undervalued stocks Prioritize stability and capital preservation by reviewing companies that appear more resilient on risk measures via the 74 resilient stocks with low risk scores Hunt for under-the-radar potential by assessing a screener containing 18 high quality undiscovered gems that many investors may not be watching yet   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Everforth might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}